Patents by Inventor Christian Birkner

Christian Birkner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220106799
    Abstract: A mounting assembly for an adjustable arrest distance fall-protection system includes an offset stanchion comprising a hollow body and a first bore formed through the hollow body, an arm connected at a first end to the hollow body, and a mounting tube comprising a first end configured to fit within the hollow body and a second bore configured to align with the first bore. The fall protection system can include multiple mounting assemblies, with a fall-arrest cable extending therebetween.
    Type: Application
    Filed: October 7, 2021
    Publication date: April 7, 2022
    Inventors: Charles Christian Birkner, Vu Le
  • Publication number: 20210324453
    Abstract: The present disclosure provides a method and system for the PCR amplification of a target sequence which suppresses non-specific amplification products. The disclosure concerns the use of a primer pair optimized to amplify a nucleic acid of a contaminant in the background of genomic DNA of a first organism. When DNA from a second organism suspected for comprising the contaminant is subjected to the same PCR-based amplification reaction, detection sensitivity and specificity of the contaminant is enhanced when an amount of genomic DNA of the first organism is present in the amplification reaction.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Inventor: Christian BIRKNER
  • Patent number: 11078545
    Abstract: The present disclosure provides a method and system for the PCR amplification of a target sequence which suppresses non-specific amplification products. The disclosure concerns the use of a primer pair optimized to amplify a nucleic acid of a contaminant in the background of genomic DNA of a first organism. When DNA from a second organism suspected for comprising the contaminant is subjected to the same PCR-based amplification reaction, detection sensitivity and specificity of the contaminant is enhanced when an amount of genomic DNA of the first organism is present in the amplification reaction.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: August 3, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Christian Birkner
  • Publication number: 20170292148
    Abstract: The present disclosure provides a method and system for the PCR amplification of a target sequence which suppresses non-specific amplification products. The disclosure concerns the use of a primer pair optimized to amplify a nucleic acid of a contaminant in the background of genomic DNA of a first organism. When DNA from a second organism suspected for comprising the contaminant is subjected to the same PCR-based amplification reaction, detection sensitivity and specificity of the contaminant is enhanced when an amount of genomic DNA of the first organism is present in the amplification reaction.
    Type: Application
    Filed: June 19, 2017
    Publication date: October 12, 2017
    Inventor: Christian Birkner
  • Publication number: 20160264925
    Abstract: The invention provides a composition containing an aqueous liquid phase, bacterial cells, and an ionic compound dissolved in the liquid phase. The ionic compound is selected from the group consisting of 1-butyl-3-methyl-imidazolium-thiocyanate, 1-butyl-3-methyl-imidazolium-2(2-methoxy-ethoxy)ethylsulfate, 1-methyl-1-[4-(3-methyl-3H-imidazol-1-ium)-but-1-yl]-3H-imidazolium-di(toluylsulfate), and 1-butyl-3-methyl-imidazolium-octylsulfate. The compositions of the invention are advantageously used for preparing lysates of biological cells, particularly bacterial cells.
    Type: Application
    Filed: May 23, 2016
    Publication date: September 15, 2016
    Inventors: Christian Birkner, Herbert von der Eltz, Monika Soukopova
  • Patent number: 9371509
    Abstract: The invention provides a composition containing an aqueous liquid phase, bacterial cells, and an ionic compound dissolved in the liquid phase. The ionic compound is selected from the group consisting of 1-butyl-3-methyl-imidazolium-thiocyanate, 1-butyl-3-methyl-imidazolium-2(2-methoxy-ethoxy)ethylsulfate, 1-methyl-1-[4-(3-methyl-3H-imidazol-1-ium)-but-1-yl]-3H-imidazolium-di(toluylsulfate), and 1-butyl-3-methyl-imidazolium-octylsulfate. The compositions of the invention are advantageously used for preparing lysates of biological cells, particularly bacterial cells.
    Type: Grant
    Filed: August 13, 2010
    Date of Patent: June 21, 2016
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Birkner, Herbert von der Eltz, Monika Soukupova
  • Publication number: 20150086990
    Abstract: The present disclosure provides a method and system for the PCR amplification of a target sequence which suppresses non-specific amplification products. The disclosure concerns the use of a primer pair optimized to amplify a nucleic acid of a contaminant in the background of genomic DNA of a first organism. When DNA from a second organism suspected for comprising the contaminant is subjected to the same PCR-based amplification reaction, detection sensitivity and specificity of the contaminant is enhanced when an amount of genomic DNA of the first organism is present in the amplification reaction.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 26, 2015
    Inventor: Christian Birkner
  • Publication number: 20120129181
    Abstract: The present disclosure provides a method and system for the PCR amplification of a target sequence which suppresses non-specific amplification products. The disclosure concerns the use of a primer pair optimized to amplify a nucleic acid of a contaminant in the background of genomic DNA of a first organism. When DNA from a second organism suspected for comprising the contaminant is subjected to the same PCR-based amplification reaction, detection sensitivity and specificity of the contaminant is enhanced when an amount of genomic DNA of the first organism is present in the amplification reaction.
    Type: Application
    Filed: February 1, 2012
    Publication date: May 24, 2012
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventor: Christian Birkner
  • Patent number: 8101744
    Abstract: Disclosed are water-soluble ionic liquids suitable for promoting adsorption of nucleic acids to a solid phase. The use thereof, particularly methods for the isolation of nucleic acids from an aqueous solution, as well as kits for performing those methods are disclosed.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: January 24, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Birkner, Herbert Von der Eltz
  • Patent number: 8053213
    Abstract: Disclosed is a method for analyzing nucleic acids in a sample comprising the following steps: (i) adding a DNA binding dye containing a benzothiazolium or benzoxazolium group to the sample to be analyzed, (ii) carrying out a polymerase chain reaction, (iii) applying the sample to a gel matrix, (iv) separating the nucleic acid molecules according to their size by applying a voltage and (v) excitation with light of a suitable wavelength for the optical visualization of the nucleic acid/DNA binding dye complexes.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: November 8, 2011
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Christian Birkner
  • Publication number: 20110053251
    Abstract: The invention provides a composition containing an aqueous liquid phase, bacterial cells, and an ionic compound dissolved in the liquid phase. The ionic compound is selected from the group consisting of 1-butyl-3-methyl-imidazolium-thiocyanate, 1-butyl-3-methyl-imidazolium-2(2-methoxy-ethoxy)ethylsulfate, 1-methyl-1-[4-(3-methyl-3H-imidazol-1-ium)-but-1-yl]-3H-imidazolium-di(toluylsulfate), and 1-butyl-3-methyl-imidazolium-octylsulfate. The compositions of the invention are advantageously used for preparing lysates of biological cells, particularly bacterial cells.
    Type: Application
    Filed: August 13, 2010
    Publication date: March 3, 2011
    Inventors: Christian Birkner, Herbert von der Eltz, Monika Soukupova
  • Publication number: 20100330579
    Abstract: Disclosed is a method for analyzing nucleic acids in a sample comprising the following steps: (i) adding a DNA binding dye containing a benzothiazolium or benzoxazolium group to the sample to be analyzed, (ii) carrying out a polymerase chain reaction, (iii) applying the sample to a gel matrix, (iv) separating the nucleic acid molecules according to their size by applying a voltage and (v) excitation with light of a suitable wavelength for the optical visualization of the nucleic acid/DNA binding dye complexes.
    Type: Application
    Filed: September 7, 2010
    Publication date: December 30, 2010
    Inventor: Christian Birkner
  • Patent number: 7803935
    Abstract: Biscationic organic compounds are disclosed which promote adsorption of nucleic acids from an aqueous solution to a solid phase such as silica. Adsorption takes place under low salt conditions. Further disclosed are methods and kits suitable for nucleic acid isolation from aqueous solutions.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: September 28, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Christian Birkner
  • Patent number: 7781165
    Abstract: The present invention is directed to the use of a benzimidazolium compound comprising a side chain at at least one of its N-residues, said chain being either a Cn-alkyl or a substituted Cn-alkyl, characterized in that preferably n is ?3, as an additive for a nucleic acid amplification reaction.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: August 24, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Birkner, Frank Bergmann, Herbert von der Eltz
  • Patent number: 7770392
    Abstract: A control apparatus for an internal combustion engine has an exhaust-gas turbocharger regulator which, as a function of a setpoint boost pressure and an actual boost pressure, determines a controlled actuating-variable exhaust-gas back-pressure. An exhaust-gas recirculation regulator determines, as a function of a setpoint air mass flow and an actual air mass flow, a controlled actuating-variable exhaust-gas recirculation mass flow. A first decoupling unit determines a decoupling mass flow in an exhaust-gas section. A second decoupling unit determines a decoupling exhaust-gas back-pressure. A first conversion unit determines a signal for the exhaust-gas turbocharger actuator as a function of the pilot-control actuating-variable exhaust-gas back-pressure, the controlled actuating-variable exhaust-gas back-pressure and the decoupling mass flow.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: August 10, 2010
    Assignee: Continental Automotive GmbH
    Inventors: Christian Birkner, Anselm Schwarte
  • Patent number: 7501240
    Abstract: The invention is related to the detection of a methylated cytosine in a nucleic acid wherein guanidinium hydrogen sulfite is used for the preparation of a solution containing guanidinium ions and sulfite ions and subsequent modification of the nucleic acid. Thereby, a non-methylated cytosine is converted to uracil. The invention further discloses kits for performing the methods of the invention.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: March 10, 2009
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Christian Birkner, Christine Markert-Hahn, Herbert von der Eltz
  • Publication number: 20090012285
    Abstract: Biscationic organic compounds are disclosed which promote adsorption of nucleic acids from an aqueous solution to a solid phase such as silica. Adsorption takes place under low salt conditions. Further disclosed are methods and kits suitable for nucleic acid isolation from aqueous solutions.
    Type: Application
    Filed: April 18, 2008
    Publication date: January 8, 2009
    Inventor: Christian Birkner
  • Publication number: 20080319182
    Abstract: Disclosed are water-soluble ionic liquids suitable for promoting adsorption of nucleic acids to a solid phase. The use thereof, particularly methods for the isolation of nucleic acids from an aqueous solution, as well as kits for performing those methods are disclosed.
    Type: Application
    Filed: April 18, 2008
    Publication date: December 25, 2008
    Inventors: Christian Birkner, Herbert Von der Eltz
  • Patent number: 7451740
    Abstract: In an adaptation method of an internal combustion engine for optimized combustion, the actually supplied cylinder-specific air masses are determined by determining the change in speed of the internal combustion engine within a thrust phase and by assigning these changes in speed to the cylinder-specific compression phases 20. This enables the fuel quantity to be injected to be more precisely adjusted to the cylinder-specific air mass available.
    Type: Grant
    Filed: July 9, 2007
    Date of Patent: November 18, 2008
    Assignee: Siemens VDO Automotive AG
    Inventors: Christian Birkner, Joris Fokkelman, Karl Müller
  • Publication number: 20080104957
    Abstract: A control apparatus for an internal combustion engine has an exhaust-gas turbocharger regulator which, as a function of a setpoint boost pressure and an actual boost pressure, determines a controlled actuating-variable exhaust-gas back-pressure. An exhaust-gas recirculation regulator determines, as a function of a setpoint air mass flow and an actual air mass flow, a controlled actuating-variable exhaust-gas recirculation mass flow. A first decoupling unit determines a decoupling mass flow in an exhaust-gas section. A second decoupling unit determines a decoupling exhaust-gas back-pressure. A first conversion unit determines a signal for the exhaust-gas turbocharger actuator as a function of the pilot-control actuating-variable exhaust-gas back-pressure, the controlled actuating-variable exhaust-gas back-pressure and the decoupling mass flow.
    Type: Application
    Filed: March 28, 2006
    Publication date: May 8, 2008
    Inventors: Christian Birkner, Anselm Schwarte